<DOC>
	<DOCNO>NCT02990624</DOCNO>
	<brief_summary>Ultraviolet ( UV ) phototherapy standard treatment many inflammatory dermatological disease , include psoriasis . The systemic effect UV phototherapy still well study . There several factor may affect patient 's cardiovascular ( CV ) risk UV phototherapy . Atherosclerosis known inflammatory origin frequently associate psoriasis . In study investigator aim study effect psoralen-UVA phototherapy several biomarkers CV risk patient psoriasis without atherosclerosis .</brief_summary>
	<brief_title>Cardiovascular Risk Evaluation Psoriasis Treated With Photochemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>Disease affect &gt; 10 % body surface area Patient willing commit 3 session weekly 36 month without interruption Disease severity le 10 % body surface area Patients unable commit therapeutic schedule due work residence issue . pregnant lactating female photosensitive dermatosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>psoriasis</keyword>
	<keyword>photochemotherapy</keyword>
	<keyword>atherosclerosis</keyword>
	<keyword>metabolic syndrome</keyword>
	<keyword>cardiovascular risk</keyword>
</DOC>